Clinical Trial Update: Oral N-acetylglucosamine in Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating oral N-acetylglucosamine for Crohn's disease is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• N-acetylglucosamine (N-acetylglucosamine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Crohns Disease | Phase 2 | Status: NOT_YET_RECRUITING